These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 14872420)

  • 1. A clinical review of bleeding dilemmas in trauma.
    Hoyt DB
    Semin Hematol; 2004 Jan; 41(1 Suppl 1):40-3. PubMed ID: 14872420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant activated factor VIIa and hemostasis in critical care: a focus on trauma.
    Mohr AM; Holcomb JB; Dutton RP; Duranteau J
    Crit Care; 2005; 9 Suppl 5(Suppl 5):S37-42. PubMed ID: 16221318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant factor VIIa (rFVIIa) and its use in severe bleeding in surgery and trauma: a review.
    Grounds M
    Blood Rev; 2003 Sep; 17 Suppl 1():S11-21. PubMed ID: 14697209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe intra-abdominal bleeding post liver biopsy - failure to respond to recombinant Factor VII.
    Quinn JP; Murphy PT
    Thromb Haemost; 2004 Mar; 91(3):632-3. PubMed ID: 14983243
    [No Abstract]   [Full Text] [Related]  

  • 5. Intraoperative pediatric blood transfusion therapy: a review of common issues. Part II: transfusion therapy, special considerations, and reduction of allogenic blood transfusions.
    Barcelona SL; Thompson AA; Coté CJ
    Paediatr Anaesth; 2005 Oct; 15(10):814-30. PubMed ID: 16176309
    [No Abstract]   [Full Text] [Related]  

  • 6. Updates in the management of severe coagulopathy in trauma patients.
    Lynn M; Jeroukhimov I; Klein Y; Martinowitz U
    Intensive Care Med; 2002 Oct; 28 Suppl 2():S241-7. PubMed ID: 12404093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systematic review.
    Levi M; Peters M; Büller HR
    Crit Care Med; 2005 Apr; 33(4):883-90. PubMed ID: 15818119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose recombinant activated factor VII in massively transfused trauma patients with coagulopathy.
    Bauzá G; Hirsch E; Burke P; Quillen K
    Transfusion; 2007 Apr; 47(4):749-51. PubMed ID: 17381636
    [No Abstract]   [Full Text] [Related]  

  • 9. Pediatric off-label use of recombinant factor VIIa.
    Alten JA; Benner K; Green K; Toole B; Tofil NM; Winkler MK
    Pediatrics; 2009 Mar; 123(3):1066-72. PubMed ID: 19255041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential role of recombinant activated factor VII for the treatment of severe bleeding associated with disseminated intravascular coagulation: a systematic review.
    Franchini M; Manzato F; Salvagno GL; Lippi G
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):589-93. PubMed ID: 17890943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant activated coagulation factor VII and bleeding trauma patients.
    Rizoli SB; Nascimento B; Osman F; Netto FS; Kiss A; Callum J; Brenneman FD; Tremblay L; Tien HC
    J Trauma; 2006 Dec; 61(6):1419-25. PubMed ID: 17159685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of recombinant activated factor VII in securing haemostatic failure in gun shot trauma.
    Shamsi T; Tufail M; Aftab M; Ansari S
    J Pak Med Assoc; 2006 May; 56(5):238-41. PubMed ID: 16767955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety profile of recombinant factor VIIa.
    Roberts HR; Monroe DM; Hoffman M
    Semin Hematol; 2004 Jan; 41(1 Suppl 1):101-8. PubMed ID: 14872430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant factor VIIa and trauma: treatment that does not leave you in the cold.
    Levi M
    J Thromb Haemost; 2007 Feb; 5(2):242-3. PubMed ID: 17181827
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of intra-abdominal bleeding with recombinant activated factor VII in a patient with disseminated intravascular coagulation secondary to septic shock.
    Martínez J; Cid AR; de la Rubia J; Gimeno R
    Blood Coagul Fibrinolysis; 2005 Jun; 16(4):297-9. PubMed ID: 15870551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of critical bleeding in trauma patients.
    Chiara O; Cimbanassi S; Brioschi PR; Bucci L; Terzi V; Vesconi S
    Minerva Anestesiol; 2006 Jun; 72(6):383-7. PubMed ID: 16682905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant factor VIIa and the trauma patient.
    Criddle LM
    J Emerg Nurs; 2006 Oct; 32(5):404-8. PubMed ID: 16997029
    [No Abstract]   [Full Text] [Related]  

  • 18. Recombinant factor VIIa after amniotic fluid embolism and disseminated intravascular coagulopathy.
    Lim Y; Loo CC; Chia V; Fun W
    Int J Gynaecol Obstet; 2004 Nov; 87(2):178-9. PubMed ID: 15491576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant factor VIIa in paediatric bleeding disorders--a 2006 review.
    Mathew P; Young G
    Haemophilia; 2006 Sep; 12(5):457-72. PubMed ID: 16919075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of recombinant activated factor VII (NovoSeven) in three cases of uncontrolled bleeding caused by disseminated intravascular coagulopathy.
    Schmid S; Friesenecker B; Lorenz I; Innerhofer P; Koscielny J; Velik-Salchner C; Mutz N; Fries D
    Clin Appl Thromb Hemost; 2007 Jul; 13(3):313-7. PubMed ID: 17636194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.